+11,254.3%
LRCX vs IVZ
+930.4%
+10,323.9%
-87.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | IVZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.8% | -3.1% | -0.7% | -2.3% |
| 7D | -12.9% | -1.7% | -11.2% | -12.2% |
| 30D | -22.7% | -2.8% | -19.9% | -21.2% |
| 3M | -33.6% | -13.1% | -20.5% | -28.6% |
| 6M | -25.4% | +6.4% | -31.8% | -26.7% |
| YTD | +19.3% | +8.9% | +10.4% | +15.8% |
| 1Y | +37.5% | +24.9% | +12.7% | +25.1% |
| 3Y | +198.2% | +127.0% | +71.1% | +101.3% |
| 5Y | +232.5% | +42.2% | +190.3% | +175.8% |
| 10Y | +2,122.3% | +37.8% | +2,084.5% | +1,604.6% |
| All | +11,254.3% | +930.4% | +10,323.9% | +3,423.7% |
Cumulative growth
Daily Returns
Daily percentage return beside IVZ.
Daily Out/Under-Performance
Portfolio return minus IVZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling